Ellis Investment Partners’s Colgate-Palmolive CL Stock Holding History

Ellis Investment Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	+2,357	New	+$206K	0.03%	271
2025 Q1	–	Sell	-2,496	Closed	-$227K	–	237
2024 Q4	$227K	Buy	2,496 +3	+0.1%	+$286	0.04%	218
2024 Q3	$259K	Buy	2,493 +2	+0.1%	+$204	0.05%	205
2024 Q2	$242K	Buy	2,491 +18	+0.7%	+$1.66K	0.05%	204
2024 Q1	$223K	Buy	+2,473	New	+$210K	0.05%	203
2022 Q4	–	Sell	-2,456	Closed	-$172K	–	293
2022 Q3	$172K	Buy	2,456 +456	+23%	+$35.8K	0.05%	206
2022 Q2	$160K	Hold	2,000	–	–	0.04%	235
2022 Q1	$151K	Hold	2,000	–	–	0.04%	271
2021 Q4	$170K	Hold	2,000	–	–	0.04%	251
2021 Q3	$151K	Sell	2,000 -300	-13%	-$23.8K	0.04%	252
2021 Q2	$187K	Hold	2,300	–	–	0.05%	215
2021 Q1	$181K	Hold	2,300	–	–	0.05%	208
2020 Q4	$197K	Hold	2,300	–	–	0.06%	187
2020 Q3	$177K	Hold	2,300	–	–	0.06%	187
2020 Q2	$167K	Hold	2,300	–	–	0.06%	180
2020 Q1	$150K	Hold	2,300	–	–	0.07%	147
2019 Q4	$156K	Hold	2,300	–	–	0.05%	175
2019 Q3	$164K	Hold	2,300	–	–	0.06%	166
2019 Q2	$165K	Buy	+2,300	New	+$163K	0.06%	167

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ellis Investment Partners's CL Position: Q2 2026 in Review

Ellis Investment Partners opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,357 shares worth $216K. The stake represents 0.03% of the portfolio and ranks #271 among its holdings. This is a return to the name: Ellis Investment Partners previously reported a position in CL as recently as Q4 2024.

Ellis Investment Partners first reported a position in CL in Q2 2019 and has held it in 19 quarters since. The position peaked at $259K in Q3 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Ellis Investment Partners held 2,357 shares of Colgate-Palmolive worth $216K as of Q2 2026.
Colgate-Palmolive was a new Ellis Investment Partners position in Q2 2026.
Colgate-Palmolive made up 0.03% of Ellis Investment Partners's portfolio in Q2 2026, its #271 holding.
Ellis Investment Partners first reported a position in Colgate-Palmolive in Q2 2019 and has held it in 19 quarters since.
Ellis Investment Partners's Colgate-Palmolive position peaked at $259K in Q3 2024.
2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.